Gabapentin as a potential option for treatment of sciatica

Area of Science:

• Neurology
• Pain Management

Background:

• Gabapentin is FDA-approved for epilepsy and postherpetic neuralgia.
• It is also effective for off-label uses like diabetic peripheral neuropathy and trigeminal neuralgia.
• No published data existed on gabapentin's efficacy for sciatica.

Observation:

• Two patients with sciatica, unresponsive to conventional treatments, were treated with gabapentin.
• The first patient had sciatica due to a lumbar disk herniation.
• The second patient had sciatica with burning pain and numbness, complicated by renal insufficiency.

Findings:

• Gabapentin significantly improved pain in both patients.
• The first patient experienced substantial relief after initial gabapentin doses and complete resolution post-surgery with continued gabapentin.
• The second patient showed rapid pain improvement with a titrated gabapentin regimen.

Implications:

• These case reports suggest gabapentin is a viable treatment for sciatica.
• Gabapentin's potential to prevent central sensitization warrants early consideration in sciatica management.
• Further randomized, placebo-controlled trials are necessary to confirm gabapentin's benefit in sciatica treatment.